Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosiglitazone and Insulin Resistance in Renally Impaired Patients

NCT00452166 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT00452166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00452166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosiglitazone and Insulin Resistance in Renally Impaired Patients
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2007
Completion date
May 31, 2008
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, insulin resistance